Replies to post #2640 on Theralase Technologies Inc (TLTFF)

[123414]

a low dose which is the therapeutic dose. ceo jan 17 2017.

is the statement that the CEO make and iS in perfect line with the .35 low dose.

TS 1:43 CEO "in that clinical study that's being conducted at UHN that's one of the top two cancer facilities in the world...with this study were enrolling 3 patients and treating them at a low dose which is the therapeutic dose.







http://www.kereport.com/2017/01/17/date-theralase-beginning-phase-1b-clinical-trial/

[Geo2014]

EXACTLY and THANK YOU!!!!!!